A recent study indicates that non-genetic adaptations play a pivotal role, involving the rewiring of oncogenic signaling pathways, intricate reciprocal interactions between cancer cells and the tumor microenvironment (TME), and the dynamic phenotypic plasticity exemplified by EMT in adaptive resistance to KRAS-G12C inhibition (Ning et al., 2022). This evidence concerns the gene KRAS and neoplasm.